QuantTheta
Posted - 1 week ago
$DGX is holding strong - its bullish without vaccines more people will need its service :-)
THESTOCKWATCHGURU
Posted - 1 week ago
$DGX this is one of the most slept on stocks
Seanwishwise
Posted - 1 week ago
$TTOO in oversold zone. Anticipating a potential rebound. Collaboration with prxcision may help in enhancing diagnostic capabilities. $DGX $LH $TMO $ABT
Sunnyfl0wer
Posted - 1 week ago
$NVAX $DGX $TSLA $LNTH $RIVN
Stocksrunner
Posted - 1 week ago
Ready for some market magic? $LNTH $DGX $NVAX $RIVN and $TSLA are stirring up buzz with their short interest stories. which one’s your pick for the next big move? https://stocksrunner.com/posts/1360
insiderbuyingselling
Posted - 2 weeks ago
$DGX new insider selling: 18755 shares. http://insiderbuyingselling.com/?t=DGX
insiderbuyingselling
Posted - 10/30/24
$DGX new insider selling: 1775 shares. http://insiderbuyingselling.com/?t=DGX
Thestocktraderhubzee
Posted - 10/28/24
WATCHLIST OCT 29 2024
$LOGI Loop Capital Maintains Hold on Logitech International, Lowers Price Target to $81
$RVMD Guggenheim Maintains Buy on Revolution Medicines, Raises Price Target to $82
$DGX Piper Sandler Maintains Neutral on Quest Diagnostics, Raises Price Target to $165
$BFH TD Cowen Maintains Hold on Bread Finl Hldgs, Raises Price Target to $50
$GBCI Piper Sandler Maintains Neutral on Glacier Bancorp, Raises Price Target to $45
Small_time_trader
Posted - 1 month ago
$DGX No one selling !!
WeeklyTrader
Posted - 1 month ago
Join the rally! A CALL on $DGX at strike None could be your ticket! RSI: 63.99% 50-day MA: $152.62 200-day MA: $139.7
JackDarwin
Posted - 1 month ago
$DGX Bullish Gap Up Formed. https://www.stockaio.com/US/ai/Stock/DGX/Candlestick
Stocksrunner
Posted - 1 month ago
$DGX Quest Diagnostics crushed Q3! EPS $2.30 vs $2.26 expected, revenue up 8.5% YoY. New customer wins driving growth. My take: Strong execution + raised guidance = bullish momentum. Rating: Buy, expect continued upward trend. 🔥
Small_time_trader
Posted - 1 month ago
$DGX
Small_time_trader
Posted - 1 month ago
$DGX boom
💥 That’s what we can an old fashioned Beat & Raise.
jj360dx
Posted - 1 month ago
$DGX 💪🏾
DonCorleone77
Posted - 1 month ago
$DGX Quest Diagnostics narrows FY24 adjusted EPS view to $8.85-$8.95 from $8.80-$9.00 Consensus $8.85. Raises FY24 revenue view to $9.8B-$9.85B from $9.5B-$9.58B, consensus $9.67B. Backs FY24 capital expenditures view $420M. "We have increased our 2024 revenue guidance due to contributions from recent acquisitions and have maintained the midpoint of our adjusted EPS guidance despite the impact of Hurricane Milton in the fourth quarter," Davis continued. "Given the strength of our business and revenue from acquisitions, we are well positioned to drive accelerated revenue and earnings growth in 2025."
DonCorleone77
Posted - 1 month ago
$DGX Quest Diagnostics reports Q3 adjusted EPS $2.30, consensus $2.26 Reports Q3 revenue $2.49B, consensus $2.42B. "We delivered a strong third quarter, with total revenue growth of 8.5%, including 4.2% organic growth," said Jim Davis, chairman, CEO and president. "Our performance was driven by new customer wins and expanded business with physicians and hospitals as well as recent acquisitions, including LifeLabs. We are now on track to complete eight acquisitions by year's end that meet our criteria for profitability, growth and returns."
Thestocktraderhubzee
Posted - 1 month ago
$DGX Quest Diagnostics Q3 2024 Adj. EPS $2.30 Beats $2.26 Estimate, Sales $2.488B Beat $2.423B Estimate
swingingtech
Posted - 1 month ago
$QCOM $DGX $CELH
https://wallstreetwaves.com/notable-monday-option-activity-qcom-dgx-celh/
ChessGM
Posted - 1 month ago
$DGX "Upcoming earnings: 10/22/2024, Consensus Signal: Bullish (7.2) The recent analysis surrounding Baker Hughes (BKR) indicates a positive outlook, primarily driven by strategic developments and anticipated earnings growth. The company has made headlines with its largest-ever order for Integrated Compressor Line units, which underscores its robust position in the energy sector. Furthermore, collaborations with Repsol on AI-driven technologies are poised to enhance operational efficiency and sustainability, aligning with current market trends toward decarbonization. Analysts have also raised their price targets for Baker Hughes, reflecting confidence in its strong exposure to the liquefied natural gas market and the potential for margin expansion in the oilfield services sector. While the overall sentiment remains optimistic, there are mixed signals regarding its upcoming earnings, with some reports suggesting that the company may not possess the ideal conditions for a significant earnings beat. However, the aggregate of favorable developments and strategic initiatives positions Baker Hughes favorably in the eyes of investors. In terms of upcoming earnings, Baker Hughes is set to release its third-quarter results on October 22, 2024, at 5 p.m. Eastern Time, followed by a webcast discussion on October 23, 2024, at 9:30 a.m. Eastern Time. This earnings report will be crucial for investors, especially given the mixed signals from recent analyses about the company's potential for an earnings beat. While some analysts express caution, indicating that Baker Hughes may not have the necessary components for significant growth, others remain optimistic about its strong market position and the favorable commodity pricing scenario that could bolster demand for its services in the oilfield sector. Investors are advised to keep an eye on these developments as they prepare for the earnings release, which could further clarify the company’s trajectory. Follow us! Do not miss other earnings alerts from ChessGM."
WeeklyTrader
Posted - 1 month ago
It's a bear party for $DGX! RSI: 41.82% 50-day MA: $152.36 200-day MA: $139.39
WeeklyTrader
Posted - 1 month ago
Let’s share strategies for dealing with $DGX! RSI: 40.66% 50-day MA: $152.38 200-day MA: $139.33
Article_AI
Posted - 1 month ago
$DGX Balancing Growth Prospects and Challenges: A Hold Recommendation for Quest Diagnostics Analyst Eric Coldwell from Robert W. Baird reiterated a Hold rating on Quest Diagnostics (DGX – Research Report) and increased the price target to ... https://www.stck.pro/news/DGX/90606424/
JackDarwin
Posted - 09/26/24
$DGX Nice Bullish Engulfing Formed. https://www.stockaio.com/US/ai/Stock/DGX/Candlestick
Stock_Titan
Posted - 09/25/24
$DGX Quest Diagnostics to Release Third Quarter 2024 Financial Results on October 22, 2024
https://www.stocktitan.net/news/DGX/quest-diagnostics-to-release-third-quarter-2024-financial-results-on-y4xa1zmmgzek.html
tlivian
Posted - 2 months ago
@Esau815 from a product perspective what do you think? I did some digging and $PMD is mighty proud of their patented process, but employers don't seem to care as much about that distinction. Labs like $DGX and $LH offer similar services and have partnered with different labs, while also offering the more common urine drug test. Do you think with that annual savings of not being a public company they can make a dent or with the issues with trying to be a public company they were stretched too thin or possibly sandbagging to buy the company for a song?
Sasnak
Posted - 2 months ago
$VCYT wow. The Decipher data looks great. Wonder when $DGX or LabCorp takes notice and buys them up?
